Apomorphine: Effect, Medical Applications, Side Effects

How apomorphine works Apomorphine mimics the neurotransmitter dopamine in the central nervous system and binds to its docking sites (receptors). In this way, the active ingredient mediates the effects typical of dopamine. Parkinson’s disease: In Parkinson’s disease, nerve cells that produce and secrete dopamine gradually die. The use of apomorphine can therefore be helpful. However, … Apomorphine: Effect, Medical Applications, Side Effects

Physiotherapy for Parkinson’s disease

Physiotherapy is essential for patients suffering from Parkinson’s disease to maintain their independence for a long time. Depending on how advanced Parkinson’s disease is, physiotherapy in functional training targets those activities where the patient feels the greatest restrictions in everyday life. Parkinson’s disease (PD) is defined as a condition in which a patient displays four … Physiotherapy for Parkinson’s disease

Erectile Dysfunction: Causes and Treatment

Symptoms Erectile dysfunction or so-called erectile dysfunction refers to the persistent or recurrent inability to achieve or maintain an erection, which is necessary for sexual activity. This makes sexual intercourse impossible and severely limits sexual life. For the affected man, erectile dysfunction can be a great psychological burden. It can trigger stress, negatively affect self-esteem … Erectile Dysfunction: Causes and Treatment

Dihydroergocriptine

Products Dihydroergocriptine is no longer registered in many countries. Cripar is out of commerce. Effects Dihydroergocriptine (ATC N04BC03) is dopaminergic and acts selectively on D2 receptors. It has no activity on serotoninergic or adrenergic receptors. Indications Parkinson’s disease Early stages of Parkinson’s disease, as monotherapy or in combination with an L-dopa preparation. Interval treatment of … Dihydroergocriptine

Rivastigmine

Products Rivastigmine is commercially available as capsules, oral solution, and transdermal patch (Exelon, generics). It has been approved in many countries since 1997. Structure and properties Rivastigmine (C14H22N2O2, Mr = 250.3 g/mol) is a phenyl carbamate. It exists in the oral forms as rivastigmine hydrogenotartrate, a white crystalline powder that is very soluble in water. … Rivastigmine

Entacapon

Products Entacapone was commercially available in the form of film-coated tablets (Comtan). It was approved in many countries since 1999. In 2017, distribution was discontinued. A fixed combination with levodopa and carbidopa has also been available since 2004 (Stalevo). Generic versions of the combination drug were approved in 2014. Structure and properties Entacapone (C14H15N3O5, Mr … Entacapon

Benserazide

Products Benserazide is commercially available in fixed combination with levodopa in tablet and capsule form (Madopar). It has been approved in many countries since 1973. Structure and properties Benserazide (C10H15N3O5, Mr = 257.2 g/mol) is a racemate. It exists as benserazide hydrochloride, a white to yellowish-white or orange-white crystalline powder that is readily soluble in … Benserazide

Amantadine

Products Amantadine is commercially available as film-coated tablets, capsules, and an infusion solution (Symmetrel, PK-Merz). It has been approved in many countries since 1966. Structure and properties Amantadine (C10H17N, Mr = 151.2 g/mol) is present in drugs as amantadine sulfate or amantadine hydrochloride. Amantadine hydrochloride is a white crystalline powder that is readily soluble in … Amantadine

Transdermal Patches

Products Transdermal patches are approved as medicinal products. They offer themselves as an alternative to other modes of application such as peroral and parenteral administration. The first products were launched in the 1970s. Structure and properties Transdermal patches are flexible pharmaceutical preparations of varying sizes and thinness that contain one or more active ingredients. They … Transdermal Patches

Clozapine

Products Clozapine is commercially available in tablet form (Leponex, generic). It has been approved in many countries since 1972. It is also known as Clozaril in some countries. Clozapine was developed at Wander and Sandoz. Structure and properties Clozapine (C18H19ClN4, Mr = 326.8 g/mol) exists as a yellow crystalline powder that is practically insoluble in … Clozapine